[HTML][HTML] Pharmacological treatment of vascular dementia: a molecular mechanism perspective

H Kuang, ZF Zhou, YG Zhu, ZK Wan, MW Yang… - Aging and …, 2021 - ncbi.nlm.nih.gov
Vascular dementia (VaD) is a neurodegenerative disease, with cognitive dysfunction
attributable to cerebrovascular factors. At present, it is the second most frequently occurring …

Neuronal ryanodine receptors in development and aging

N Abu-Omar, J Das, V Szeto, ZP Feng - Molecular neurobiology, 2018 - Springer
Ryanodine receptors (RyRs) are intracellular calcium-release channels found on the
endoplasmic reticulum of all cells. All three RyR isoforms, RyR1–3, are expressed in the …

A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease

SO Rahman, RK Singh, S Hussain, M Akhtar… - European Journal of …, 2019 - Elsevier
Cysteinyl leukotrienes (cysLTs) are member of eicosanoid inflammatory lipid mediators
family produced by oxidation of arachidonic acid by action of the enzyme 5-lipoxygenase (5 …

Montelukast prevents early diabetic retinopathy in mice

R Bapputty, R Talahalli, S Zarini, I Samuels… - Diabetes, 2019 - Am Diabetes Assoc
Chronic inflammation and oxidative stress are critical components in the pathogenic
cascade of early diabetic retinopathy, characterized by neuronal and vascular degeneration …

Ruthenium red, mitochondrial calcium uniporter inhibitor, attenuates cognitive deficits in STZ-ICV challenged experimental animals

Y Sharma, D Garabadu - Brain Research Bulletin, 2020 - Elsevier
Alzheimer's disease (AD) is a progressive neurodegenerative disorder with cardinal features
of cognitive dysfunction in an individual. Recently, the blockade of mitochondrial calcium …

Recent trends in the management of Alzheimer's disease: current therapeutic options and drug repurposing approaches

RK Singh - Current Neuropharmacology, 2020 - ingentaconnect.com
Alzheimer's disease is one of the most progressive forms of dementia, ultimately leading to
death in aged populations. The major hallmarks of Alzheimer's disease include deposition of …

Salubrious effects of ulinastatin and quercetin alone or in combination in endothelial dysfunction and vascular dementia

P Sharma, N Gaur, S Jayant, BM Sharma… - Pharmacological …, 2022 - Springer
Background Vascular dementia is the second most prevalent form of dementia.
Hypertension is the leading risk factor for endothelial dysfunction and the progression of …

Neuroprotective effects of nicorandil in chronic cerebral hypoperfusion-induced vascular dementia

S Gupta, P Singh, B Sharma - Journal of Stroke and Cerebrovascular …, 2016 - Elsevier
Background Ischemia-induced chronic cerebral hypoperfusion (CCH) is associated with
reduced cerebral blood flow and vascular dementia (VaD). Brain mitochondrial potassium …

Effect of ruthenium red, a ryanodine receptor antagonist in experimental diabetes induced vascular endothelial dysfunction and associated dementia in rats

S Jain, B Sharma - Physiology & Behavior, 2016 - Elsevier
Diabetes mellitus is considered as a main risk factor for vascular dementia. In the past, we
have reported the induction of vascular dementia by experimental diabetes. This study …

Selective serotonin-norepinephrine re-uptake inhibition limits renovas-cular-hypertension induced cognitive impairment, endothelial dysfunction, and oxidative stress …

P Singh, B Sharma - Current Neurovascular Research, 2016 - ingentaconnect.com
Hypertension has been reported to induce cognitive decline and dementia of vascular
origin. Serotonin-norepinephrine reuptake transporters take part in the control of …